These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10609699)

  • 21. Towards defining the neuropathological substrates of vascular dementia.
    Kalaria RN; Kenny RA; Ballard CG; Perry R; Ince P; Polvikoski T
    J Neurol Sci; 2004 Nov; 226(1-2):75-80. PubMed ID: 15537525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E as vascular risk factor in neurodegenerative dementia.
    Folin M; Baiguera S; Conconi MT; Di Liddo R; De Carlo E; Parnigotto PP; Nussdorfer GG
    Int J Mol Med; 2004 Oct; 14(4):609-13. PubMed ID: 15375590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.
    Rojas-Fernandez CH; Moorhouse P
    Ann Pharmacother; 2009 Jul; 43(7):1310-23. PubMed ID: 19584390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is vascular dementia?
    Kurz AF
    Int J Clin Pract Suppl; 2001 May; (120):5-8. PubMed ID: 11406926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular dementia.
    Erkinjuntti T; Rockwood K
    Semin Clin Neuropsychiatry; 2003 Jan; 8(1):37-45. PubMed ID: 12567331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ten-Point Clock Test: a correlation analysis with other neuropsychological tests in dementia.
    Moretti R; Torre P; Antonello RM; Cazzato G; Bava A
    Int J Geriatr Psychiatry; 2002 Apr; 17(4):347-53. PubMed ID: 11994889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of vascular dementia: evidence from trials with non-cholinergic drugs.
    Pantoni L
    J Neurol Sci; 2004 Nov; 226(1-2):67-70. PubMed ID: 15537523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular dementia.
    Micieli G
    Neurol Sci; 2006 Mar; 27 Suppl 1():S37-9. PubMed ID: 16708182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mixed dementia: a neuropathologic point od view].
    Zekry D; Duyckaerts C; Hauw JJ
    Psychol Neuropsychiatr Vieil; 2005 Dec; 3(4):251-9. PubMed ID: 16316816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevention of the dementia epidemic.
    Korczyn AD; Vakhapova V
    J Neurol Sci; 2007 Jun; 257(1-2):2-4. PubMed ID: 17490685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of clinical criteria for possible vascular dementia in the oldest-old.
    Bacchetta JP; Kövari E; Merlo M; Canuto A; Herrmann FR; Bouras C; Gold G; Hof PR; Giannakopoulos P
    Neurobiol Aging; 2007 Apr; 28(4):579-85. PubMed ID: 16580095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vascular dementias].
    Diehl J; Kurz A
    Fortschr Neurol Psychiatr; 2002 Mar; 70(3):145-54. PubMed ID: 11880947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meeting the challenges of vascular dementia. Introduction.
    Small G
    Int J Clin Pract Suppl; 2001 May; (120):1-4. PubMed ID: 11406921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular dementia. Advances in nosology, diagnosis, treatment and prevention.
    Román GC
    Panminerva Med; 2004 Dec; 46(4):207-15. PubMed ID: 15876977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modern concept of vascular cognitive impairment.
    Bowler JV
    Br Med Bull; 2007; 83():291-305. PubMed ID: 17675645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?
    Kim JM; Lyons D; Shin IS; Yoon JS
    Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular and biochemical risk factors of vascular dementia after lacunar strokes (S-VaD) and after multiinfarcts in strategic areas (M-VaD).
    Graban A; Bednarska-Makaruk M; Bochyńska A; Lipczyńska-Łojkowska W; Ryglewicz D; Wehr H
    J Neurol Sci; 2009 Aug; 283(1-2):116-8. PubMed ID: 19339023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High b-value diffusion imaging of dementia: application to vascular dementia and alzheimer disease.
    Mayzel-Oreg O; Assaf Y; Gigi A; Ben-Bashat D; Verchovsky R; Mordohovitch M; Graif M; Hendler T; Korczyn A; Cohen Y
    J Neurol Sci; 2007 Jun; 257(1-2):105-13. PubMed ID: 17360001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1alpha and -1beta promoter polymorphisms in Taiwanese patients with dementia.
    Wang HK; Hsu WC; Fung HC; Lin JC; Hsu HP; Wu YR; Hsu Y; Hu FJ; Lee-Chen GJ; Chen CM
    Dement Geriatr Cogn Disord; 2007; 24(2):104-10. PubMed ID: 17622713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.